{"_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDE2ZCCCgw","type":"Investor","logokey":"$BRwRAKonw8Fk1F6MPTikXODt1LX1iyNdk7jW74rwRxr8B7ydyfOPty","name":"venBio","subtype":"VC and Private Equity","lastupdate":"2024-08-05T00:00:00.000Z","update_date":"2024-08-05T00:00:00.000Z","lastModified":"Aug 5, 2024","active":1,"confidence_score":55,"confidence_score_reason":"product stage, sector, number of employees, business model, tag line, video or image, funding rounds, markets, not claimed","urlname":"venbio","minimal_profile":0,"hide_reason":null,"status":"Active","fullstatus":"Active","hide_reason_data":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"isisraeli":0,"country":"United States","formernames":[],"min_date_investments":"2022-01-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":null,"founded_year":2011,"iia_supported":null,"currently_iia_supported":null,"alternativenames":["venBio Partners"],"managedassets":"$2B","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"https://www.venbio.com/","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/venbio-partners/","instagram":""},"social":["https://www.linkedin.com/company/venbio-partners/"],"flattenedsociallinks":"https://www.linkedin.com/company/venbio-partners/","apps":{"appstore":"","googleplay":""},"investmentstage":["C Round","G Round","Pre-Seed","D Round","B Round","Seed","F Round","A Round","E Round"],"about":"venBio is a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.\nThey are mindful of potential acquisition partners from the outset, and they ensure that their companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations.","founded":"1/2011","education":null,"additional_activities":null,"techcommunityinvolvement":null,"exits":[{"date":"Oct 2024","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"4rKxIkt5yzd2zEMOOxnocer2uw2GylB4os1ySXJ6al6ba3nXaWubwA","mnatype":"Acquisition","eventtype":"MNAEvent","valuation":"Undisclosed","wasacquired":1,"capitalraised":"Undisclosed","stockexchange":null,"eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"ImmPACT Bio","acquiredcompany_spac":null,"acquiringcompany_mna":"Lyell Immunopharma","stockexchange_logokey":null,"acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":"6W86QKe40FccULsEmKiz54HcTvvVHT3EY44IRgbILOpwV4wz5EAvPo","acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/immpact-bio","acquiredcompany_mna_logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","acquiredcompany_mna_urlname":"immpact-bio","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":1,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":"/mnc_page/lyell-immunopharma","acquiringcompany_mna_logokey":"$rSWeI6Y00ziAGrFGd6Y3S49F0XKjSAT35P3PgYtxcB18CtHLjm98aV.png","acquiringcompany_mna_urlname":"lyell-immunopharma","acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$rSWeI6Y00ziAGrFGd6Y3S49F0XKjSAT35P3PgYtxcB18CtHLjm98aV.png","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","acquiringcompany_style":"","acquiringcompany_hiddenCompanyTooltip":"","style":"","hiddenCompanyTooltip":""}],"funds":[{"date":"Aug 2024","name":"5","title":"Fund 5","amount":"$528M","source":"https://www.fiercebiotech.com/biotech/venture-capital-veteran-venbio-raises-528-million-life-sciences-investment","eventid":"jx0JjYlJVcKYY84C8p1mIBiWVKH8eQAMARv8tH6D0qvX3Gi31WxNKJ","visibilitytype":"Public","amountvisibility":"Public","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""},{"date":"Jun 2021","name":"4","title":"Fund 4","amount":"$550M","source":"https://www.venbio.com/firm/","eventid":"blESKMeMlE0zE0DxknFc4ENJuSOTdVi0ecv8N8eIFSWeXfI88D6SPT","visibilitytype":"Public","amountvisibility":"Public","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""}],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","name":"ImmPACT Bio","hidden":false,"raised":"$137M","founded":"2017","fullurl":"/company_page/immpact-bio","logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","urlname":"immpact-bio","employees":"11-50","description":"CAR-T Cell Therapies for Treating Cancer","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":137000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Jan 2022","name":"ImmPACT Bio","amount":111000000,"hidden":false,"islead":1,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDE9NTNCAw","fullurl":"/company_page/immpact-bio","logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","tagline":"CAR-T Cell Therapies for Treating Cancer","urlname":"/company_page/immpact-bio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","isfollowon":0,"companytype":"Startup","eventamount":"$111M","fundingtype":"B Round","investmentid":"9278c932-a387-4a55-9141-407cdc50fa36","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[{"name":"Robert Adelman","email":"robert@venbio.com","phone":"","gender":"Male","userid":"MDCq02LKALuVep16Hd0e4ECwJ3dPaMFObTXaNSURvkDS5jCg2SRI0x","bounced":true,"claimed":null,"founder":0,"urlname":"robert-adelman","visible":1,"memberid":"TgV4lT9NylKXhFUdbBRF1RojLArXGi7SRqn7oEdWu3mjV8n8xPuK9L","position":"Managing Partner","last_name":"Adelman","claimtoken":"tRk3HVWdZvngzJdIPNuAvFfa1rc8a5y4StoCT3iV5X8vonaMPGtMiy","first_name":"Robert","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-08-05 15:26:55.000000","initials":"RA","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Richard Gaster","email":"richard@venbio.com","phone":"","gender":"Male","userid":"veEfbjNsO0mPy2WmUfXhaGeUV5qPb2cFvem91qwdAXqYgF3iSG761q","bounced":false,"claimed":null,"founder":0,"urlname":"richard-gaster","visible":1,"memberid":"k6i33b330oUxZZPTCnvXJgGmwtbEi2UAjLSqZqMvqzc4xKxWK9m2ln","position":"Managing Partner","last_name":"Gaster","claimtoken":"AXgJgKCY9GlkEuT66odUdb0lxeNd4RshY8xxBvpQkzRG13olQKIF8S","first_name":"Richard","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/richard-gaster/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-08-05 15:26:57.000000","initials":"RG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Aaron Royston","email":"aaron@venbio.com","phone":"","gender":"Male","userid":"jSjhCy7Jlh6vGbwDilk7EcuLPRZzwpB52yR7RXvmPufQ8pHQhzB1rb","bounced":false,"claimed":null,"founder":0,"urlname":"aaron-royston","visible":1,"memberid":"p33zUWd3z6VXE9RarL1GUSbbxwgds4JBcZzbgHRP72Ew5cX2Jk4I9Y","position":"Managing Partner","last_name":"Royston","claimtoken":"2Qg2cZhi7hVMIM0CLB3QaTNLXJtj1eXt6JiYshurY4QpZ2aShlNe6i","first_name":"Aaron","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/aaronroyston/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-08-05 15:26:59.000000","initials":"AR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Corey Goodman","email":"corey@venbio.com","phone":"","gender":"Male","userid":"MDCq02LKALuVep16Hd0e4ECwJ3dPaMFObTXaNSURvkDS5jCg2SRI0x","bounced":false,"claimed":null,"founder":0,"urlname":"robert-adelman","visible":1,"memberid":"yCRJaGjiQ5kRcmPb2C6xVVCyWn8QxwTyOq7SmaBL85ZAoZuodtJOIP","position":"Managing Partner","last_name":"Goodman","claimtoken":"jfVdeNd00BHllW9xcwPqY1JRuG5KJe2qLti6RckmruVSpyhkCyHNcO","first_name":"Corey","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/corey-goodman-5831b1133/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-08-05 15:27:02.000000","initials":"CG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"tags":["life-sciences","biotechnology","healthcare","therapeutics"],"targetmarkets":[],"phone":null,"address":{"israeli":[],"officesabroad":[{"id":"ekzOVaYs1sReFEindGL8fp8A55bUKywUue232yUlnZNvhWkAfJs74n","city":"San Francisco","address":"San Francisco, CA, USA","country":"United States","placeid":"ChIJIQBpAG2ahYAR_6128GcTUEo"}]},"headquarter_address":null,"news":[{"id":"iUKqM6weQZ0rzCM1Bp4MapABhfMAx5uBdNfFaH2sxZKRKo9k3UINKS","date":"Aug 1, 2024","link":"https://www.fiercebiotech.com/biotech/venture-capital-veteran-venbio-raises-528-million-life-sciences-investment","source":"www.fiercebiotech.com","visible":1,"analysis":{"tags":"Investment, Acquisition","company":"venBio","layoffs":"Not mentioned","summary":"Venture capital firm venBio has raised $528 million for its fifth fund, Fund V, to invest in biotechs working on diseases with unmet needs. The fundraising began in mid-April, with investors coming from diverse backgrounds. The San Francisco-based firm plans to invest across all stages of clinical development. venBio has previously invested in over 40 companies, many of which have been acquired or gone public.","partners":"Not mentioned","customers":"Not mentioned","investors":["Sovereign wealth funds","Corporate pensions","Financial institutions","University endowments","Medical institutions","Foundations","Family offices","Funds-of-funds"],"confidence":9,"key_topics":["Venture Capital","Biotech Investment"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$528 million","structured_issues":["Investment","Acquisition"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"avceLKWNZUSMCcwnKhO06wDDAo3iA1n4vM3Di3bUxTCYL7upLpOj47","news_summary":"Venture capital veteran venBio raises $528M for life sciences investment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":1,"mediagallery":[],"biverification":"Ortal Wein","sectorverify":null,"biverify":{"id":"mVHkJWaFUni4eLEsVxEWg3vRD9hTqwtOv4UDm25gLIOSfni7yE5heF","fullname":"Ortal Wein"},"biverifydate":"2024-08-05T00:00:00.000Z","crunchbaseid":"venbio","lastupdator":"Ortal Wein","lastupdator_email":"ortalw@sncentral.org","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2022-01-20T00:00:00.000Z","recentupdates":[{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:59.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:51.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:28:08.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:27:02.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-05 15:16:15.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:36.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:35.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:17:30.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:55.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:51.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:50.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:51.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:36.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:36.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-05 15:16:16.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:51.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:56.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:35.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-05 15:16:16.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:56.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:16.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:51.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:29:51.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:28:08.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:59.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:28:08.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:27:02.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:28:08.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-05 15:16:15.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:55.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:22:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:16:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-05 15:26:36.000000","last_name":"Wein","first_name":"Ortal"}],"rounds_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"B Round"}],"investment_rounds_over_time":[{"year":2022,"month":1,"record_count":1}],"portfolio_companies_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2022,"month":1,"record_count":1}],"exits_over_time":[{"year":2024,"count":1,"eventType":"MNAEvent"}],"exits_by_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":null,"timeline":[{"id":"jx0JjYlJVcKYY84C8p1mIBiWVKH8eQAMARv8tH6D0qvX3Gi31WxNKJ","date":"2024-08-01","name":"5","title":"Fund 5","amount":528000000,"source":"https://www.fiercebiotech.com/biotech/venture-capital-veteran-venbio-raises-528-million-life-sciences-investment","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""},{"id":"blESKMeMlE0zE0DxknFc4ENJuSOTdVi0ecv8N8eIFSWeXfI88D6SPT","date":"2021-06-01","name":"4","title":"Fund 4","amount":550000000,"source":"https://www.venbio.com/firm/","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""}],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"venBio","logourl":"https://storage.googleapis.com/clean-finder-353810/$BRwRAKonw8Fk1F6MPTikXODt1LX1iyNdk7jW74rwRxr8B7ydyfOPty","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$BRwRAKonw8Fk1F6MPTikXODt1LX1iyNdk7jW74rwRxr8B7ydyfOPty","teamMembersNumber":4,"section":null,"sectionParams":"","queryParams":"","seoabout":"venBio is a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeu...","seoTitle":"Foreign VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"B Round\",\"newInvestments\":1,\"followOnInvestments\":0}],\"investmentRoundsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2024,\"count\":1,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2023,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2023,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":2000000000,"investmentrange":"$111M - $111M","communityinvolvement":[],"foreignInvestments":"","nationality":"Foreign","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}